Ventas (NYSE:VTR) Announces Earnings Results

Ventas (NYSE:VTR) released its quarterly earnings results on Tuesday. The real estate investment trust reported $0.99 EPS for the quarter, topping analysts’ consensus estimates of $0.98 by $0.01, reports. The company had revenue of $1.83 billion during the quarter, compared to analysts’ expectations of $1.77 billion. Ventas’s quarterly revenue was up 23.0% on a year-over-year basis. During the same period in the prior year, the firm earned $0.88 EPS.

Ventas Price Performance

VTR stock opened at $83.22 on Wednesday. The stock has a market capitalization of $42.69 billion, a P/E ratio of 154.12 and a beta of 0.72. The business has a fifty day moving average price of $87.67 and a 200-day moving average price of $86.31. Ventas has a 1-year low of $68.15 and a 1-year high of $101.60.

Ventas Announces Dividend

The company also recently disclosed a quarterly dividend, which was paid on Thursday, October 15th. Investors of record on Wednesday, September 30th were issued a $0.52 dividend. This represents a $2.08 dividend on an annualized basis and a yield of 2.5%. The ex-dividend date was Wednesday, September 30th. Ventas’s payout ratio is presently 385.19%.

Key Ventas News

Here are the key news stories impacting Ventas this week:

• Positive Sentiment: Ventas reported third-quarter normalized FFO of $0.99 per share, ahead of the $0.98 consensus estimate and up from $0.88 a year earlier. Revenue increased 23% year over year to $1.83 billion, exceeding the $1.77 billion forecast. Ventas Q3 Normalized FFO, Revenue Rise
• Positive Sentiment: Growth in senior housing, including strong organic performance, helped drive the quarterly beat and contributed to an increase in full-year guidance. The results suggest improving demand and operating momentum in a key Ventas business segment. Ventas Q3 2026: Senior Housing Surge Drives Guidance Raise
• Neutral Sentiment: The earnings release confirmed broad revenue and FFO growth for the quarter and first nine months of 2026. However, with a market capitalization of approximately $42.7 billion and a high reported P/E ratio, investors may require continued strong growth to support the valuation. Ventas Reports Third-Quarter and Nine-Month Results
• Negative Sentiment: BNP Paribas lowered its price target on VTR to $93 from $110. Although the revised target remains above the stock’s recent trading level, the cut signals reduced near-term upside expectations and may weigh on sentiment. BNP Paribas Adjusts Price Target on Ventas
• Negative Sentiment: VTR broke below its 200-day moving average, currently around $86.31, while also remaining below its 50-day average near $87.67. The technical breakdown can trigger additional selling and indicates weakening momentum despite the favorable earnings report. Ventas Stock Price Breaks Below 200-Day Moving Average

Analysts Set New Price Targets

Several analysts have weighed in on the stock. JPMorgan Chase & Co. boosted their price target on shares of Ventas from $94.00 to $104.00 and gave the stock an “overweight” rating in a research note on Wednesday, September 2nd. Mizuho upped their price target on shares of Ventas from $98.00 to $104.00 and gave the company an “outperform” rating in a research report on Wednesday, July 22nd. Evercore set a $100.00 price objective on Ventas and gave the company an “outperform” rating in a research note on Monday, September 21st. Citigroup lifted their price objective on Ventas from $100.00 to $110.00 and gave the stock a “buy” rating in a report on Tuesday, August 4th. Finally, BNP Paribas Exane boosted their target price on Ventas from $93.00 to $110.00 and gave the company an “outperform” rating in a research note on Thursday, July 30th. Eighteen equities research analysts have rated the stock with a Buy rating and three have issued a Hold rating to the company’s stock. According to MarketBeat.com, Ventas has an average rating of “Moderate Buy” and an average price target of $98.91.

Ventas Company Profile

Ventas, Inc (NYSE: VTR) is a real estate investment trust focused on healthcare and senior housing properties. The company owns, manages and develops a diversified portfolio of healthcare-related real estate, including senior living communities, medical office buildings, life science and innovation centers, and other properties serving healthcare providers and institutions.

Ventas generally leases its properties to healthcare operators, physicians, health systems, universities and research organizations.